-Reuters   Cheap generic drugs were meant to change the life of Nandakhu Nissar, whose mouth is swollen by a cancerous tumour. But the cashless and hungry 55-year-old sleeps on a pavement staring up at the windows of Mumbai's biggest cancer hospital.  "What is a generic drug?" shrugs Nissar, who has travelled over 1,500 kms (900 miles) from his home in the hope of treatment. "I have borrowed money from friends and relatives...

Compulsory licence can go a long way to ensure access to cheaper drugs In a momentous development, the Indian patent office issued the ever-compulsory licence in a highly contentious pharmaceutical patent case. The decision is a thumping victory for several patients and health activists who have been fighting what can only be labelled as highly inequitable pricing strategies by multinational drug firms for the past several decades. In August 2011, Natco, an...

India's use of the compulsory licensing provision under its patents law for the first time to make the patented cancer drug Nexavar available at affordable prices is an essential, although belated step to curb the mounting cost of drugs. The grant of the licence by the Controller-General of Patents, Designs and Trade Marks to Natco Pharma for manufacture of the drug Sorafenib Tosylate (Nexavar) to treat liver and kidney cancer is...

The Sonia Gandhi-led National Advisory Council (NAC) has released draft recommendations for a social security package for the country’s unorganized sector, which envisages providing life, disability and health cover, maternity benefits and old-age pension to workers. NAC, in a draft released on 7 March, suggested that the different welfare schemes being run by the ministries of women and child development, health and family welfare, finance and labour and employment should be...

Parliament must use budget session to discuss key pending bills The budget session of Parliament begins today. The last few sessions have been characterised by disruptions and consequent loss of productive time. To see one indicator, the 15th Lok Sabha, half-way through its term, has lost 30 per cent of scheduled time — the worst ever. As a result, many important bills have been pending. It is to be seen whether...